Navigation Links
Protein signal is crucial for accurate control of insect size
Date:5/4/2012

HEIDELBERG, 4 May 2012 Two independent groups of researchers have identified a hormone that is responsible for keeping the growth and development of insects on track. The results, which are reported in the journal Science, suggest that Dilp8 provides an important signal to slow body growth and delay insect development. This braking effect is an essential part of normal development since it allows sufficient time for tissues to form and the correct body size, proportions and symmetry to be achieved.

"The important question about the control of animal size is knowing when to stop," said EMBO Member Maria Dominguez, lead author of one of the papers and Professor at the Institute of Neurosciences in Alicante, Spain. "To achieve the required precision in the control of growth, organs within the body of an insect must be capable of sensing their own size and communicating their dimensions to other organs in the body and to the endocrine system." She added: "Our work with Drosophila suggests that growing organs and tissues produce a secreted peptide known as Dilp8. This hormone coordinates the growth rate of different organs in the body and is capable of delaying important developmental steps such as metamorphosis. In healthy flies, this additional time is essential to ensure that functional tissues are established and for organs to reach normal size. It also ensures that organs maintain perfect bilateral symmetry."

Dominguez and collaborators examined tumours in the eye discs of Drosophila, parts of the insect body that go on to generate fully formed eyes in mature adult flies. Developing flies often adjust growth and the timing of metamorphosis to compensate for the disturbance induced by tumours or injury. The researchers wanted to investigate if a shared molecular signal was responsible for these observations. "Our work identifies Dilp8 as a signal that communicates the growth status of tissues as well as local responses to recovery from injury and cancer," said Dominguez.

EMBO Member Pierre Lopold and collaborators from the Institute of Biology Valrose at the University of Nice, France, identified the same protein using a different experimental approach. "We used a genome-wide RNA interference approach to look for Drosophila gene candidates that might be involved in coupling growth with the timing of development. Out of 11,000 genes that we tested in our genetic screen, only one was able, upon silencing, to rescue the delay in development induced by conditions that perturb tissue growth. This candidate gene corresponded to dilp8, which is exactly same gene identified by Dominguez and collaborators."

The expression of the dilp8 gene reduces tissue growth, which suggests that in addition to its role in preventing the hormonal induction of metamorphosis, dilp8 could act by slowing the growth of healthy tissues to stay synchronized with slow-growing tissue.

Until now, little information at the molecular level has been available about how organ growth is monitored and coordinated with the timing of development in insects and other complex organisms. Dilp8 appears to be part of the molecular machinery that helps tissues to grow and develop at the right pace.


'/>"/>

Contact: Barry Whyte
barry.whyte@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert  

Related biology news :

1. Key proteins newly discovered form and function may provide novel cancer treatment target
2. In protein folding, internal friction may play a more significant role than previously thought
3. High levels of TRAIL protein in breast milk might contribute to anticancer activity
4. New study finds a protein combination is best to consume post-workout for building muscle
5. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
6. Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
7. Newly found protein helps cells build tissues
8. Plant research reveals new role for gene silencing protein
9. Protein jailbreak helps breast cancer cells live
10. New hope for treating Alzheimers Disease: A role for the FKBP52 protein
11. The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein signal is crucial for accurate control of insect size
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: